SEARCH

SEARCH BY CITATION

References

  • 1
    Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983; 85: 439462.
  • 2
    Aach RD, Lander JJ, Sherman LA, Miller WV, Kahn RA, Git-nick GL, Hollinger FB. et al. Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and nontransfused patients. In: VyasGN, CohenSN, SchmidR. eds. Viral hepatitis. Philadelphia: Franklin Institute Press, 1978: 383396.
  • 3
    Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B post-transfusion hepatitis: a decade later. Gastroenterology 1985; 88: 12511254.
  • 4
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander Wj, Hu PY. et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 18991905.
  • 5
    Esteban JI, Genesca J, Alter HJ. Hepatitis C. molecular biology, pathogenesis, epidemiology, clinical features, and prevention. In: BoyerJL, OcknerRK. eds. Progress in liver diseases. Vol X. Philadelphia: Saunders, 1992: 253282.
  • 6
    Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB. et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1991; 327: 19061911.
  • 7
    Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47: 49674972.
  • 8
    Nishioka K, Watanabe J, Furuta S, Tanaka E, Lino S, Suzuki H, Tsuji T. et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429433.
  • 9
    Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H. et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 28422847.
  • 10
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S. et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671675.
  • 11
    Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15: 572577.
  • 12
    Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567571.
  • 13
    Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC, Balart LA. et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595603.
  • 14
    Kobayashi K, Hashimoto E, Ludwig J, Hisamitsu T, Obata H. Liver biopsy features of acute hepatitis C compared with hepatitis A. B and non-A, non-B, non-C. Liver 1993; 13: 6973.
  • 15
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 15131520.
  • 16
    Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372374.
  • 17
    Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958; 53: 457481.
  • 18
    Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 248275.
  • 19
    Akaike H. Information theory and an extension of the maxiu-mum likelihood principle. In: PetrovBN, CsakiH. eds. Second international symposium on information theory. Budapest: Akademiai Kaido, 1973: 267281.
  • 20
    Dixon WJ, Brown MB, Engleman L, Frane JW, Hill MA, Jennrich RI, Toporek JD. BMDP Statistical software. Berkeley: University of California Press, 1985.
  • 21
    DeGroote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ. et al. A classification of chronic hepatitis. Lancet 1968; 2: 626628.
  • 22
    Popper H, Schaffner F. The vocabulary of chronic hepatitis. N Engl J Med 1971; 284: 11541156.
  • 23
    Scheuer PJ. Changing views on chronic hepatitis. Histopathology 1986; 10: 14.
  • 24
    Crowe J, Doyle C, Fielding JF, Holloway J, Keegan M, Kelleher D, Kelly P. et al. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [Abstract]. Gastroenterology 1995; A1054.
  • 25
    Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y. et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293299.
  • 26
    Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M. et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994; 19: 10881094.
  • 27
    Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon-alfa therapy. Gastroenterology 1993; 104: 877883.
  • 28
    Magrin S, Craxi A, Fabiano C, Simonetti RG, Florentine G, Marino L, DiQuattro O. et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment. Hepatology 1994; 19: 273279.